(ITEK) - Earnings & Price History

ITEK: - 2.51, $69.69M, -0.01 (-0.40%)

Sector: Healthcare - Industry: Biotechnology

Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma and other diseases of the eye in the United States. The companys lead product candidate includes Trabodenoson, a monotherapy that is in Phase III clinical trials for lowering IOP by restoring the eyes natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a fixed-dose combination prostaglandin analogue, which has completed the Phase II clinical trials for IOP-lowering in patients who have previously had inadequate response to latanoprost, as well as Trabodenoson monotherapy that is in pre-clinical studies for the treatment of optic neuropathy and degenerative retinal diseases. The company was founded in 1999 and is headquartered in Lexington, Massachusetts.Key Statistics

Past ITEK reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-16-0.431.8751.851.851.851.91.35%1.35%1.05M
2016-11-09-0.4576.9576.87.450.72%▲0.72%252.70K
2016-11-08-0.456.956.776.857.954.48%▲-0.71%3.73%597.94K
2016-11-07-0.456.76.66.556.46.75-0.76%▲2.29%1.52%331.86K
2016-08-10-0.46.776.696.696.66.791.20%1.20%98.65K
2016-08-05-0.4
2016-08-04-0.46.826.726.756.626.820.45%1.04%1.49%214.15K
2016-05-11-0.228.768.879.058.249.052.03%-3.20%-1.24%145.90K
2016-03-23-0.377.317.047.036.857.55-0.14%3.98%3.84%93.59K
2015-11-12-0.4610.7411.5311.410.5811.25-1.13%▲-5.79%-6.85%115.04K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades